This enzyme is detectable in the blood of patients with neuroblastoma, small cell lung cancer, medullary thyroid cancer, carcinoid tumors, pancreatic endocrine tumors, and melanoma. It is used as a tumor marker to assess the extent of the disease and to determine the patient's prognosis.